日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors

ABCB1抑制剂口服Valspodar联合紫杉醇治疗晚期实体瘤患者的I期临床试验

期刊:American Journal of Clinical Oncology-Cancer Clinical Trials
影响因子:1.8
doi:10.1097/COC.0000000000001014
Fracasso, Paula M; Fisher, George A Jr; Goodner, Sherry A; Beumer, Jan H; Egorin, Merrill J; Fears, Carole L; Wildi, Jonathan D; Jones, Gary J; Pearce, Tillman E; Sikic, Branimir I
ABCB1
发表日期：2023
文献求助 收藏

Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

更正：甲磺酸伊马替尼（格列卫；STI571）治疗复发性少突胶质细胞瘤和混合型少突星形细胞瘤的 I/II 期试验。北美中部癌症治疗组研究 N0272 (ALLIANCE/NCCTG)

期刊:Journal of Neuro-Oncology
影响因子:3.1
doi:10.1007/s11060-019-03201-3
Jaeckle, Kurt A; Anderson, S K; Twohy, Erin L; Dixon, Jesse G; Giannini, Caterina; Jenkins, Robert; Egorin, Merrill J; Sarkaria, Jann N; Brown, Paul D; Flynn, P J; Schwerkoske, John; Buckner, Jan C; Galanis, Evanthia
胶质细胞
细胞生物学
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

伊马替尼甲磺酸盐（格列卫；STI571）治疗复发性少突胶质细胞瘤和混合型少突星形细胞瘤的 I/II 期试验。北美中部癌症治疗组研究 N0272 (ALLIANCE/NCCTG)

期刊:Journal of Neuro-Oncology
影响因子:3.1
doi:10.1007/s11060-019-03194-z
Jaeckle, Kurt A; Anderson, S K; Twohy, Erin L; Dixon, Jesse G; Giannini, Caterina; Jenkins, Robert; Egorin, Merrill J; Sarkaria, Jann N; Brown, Paul D; Flynn, P J; Schwerkoske, John; Buckner, Jan C; Galanis, Evanthia
胶质细胞
细胞生物学
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia

一项针对急性髓系白血病患者的地西他滨和伏立诺他联合用药两种顺序特异性方案的 I 期临床试验

期刊:Leukemia & Lymphoma
影响因子:2.2
doi:10.3109/10428194.2015.1018248
How, Jonathan; Minden, Mark D; Brian, Leber; Chen, Eric X; Brandwein, Joseph; Schuh, Andre C; Schimmer, Aaron D; Gupta, Vikas; Webster, Sheila; Degelder, Tammy; Haines, Patricia; Stayner, Lee-Anne; McGill, Shauna; Wang, Lisa; Piekarz, Richard; Wong, Tracy; Siu, Lillian L; Espinoza-Delgado, Igor; Holleran, Julianne L; Egorin, Merrill J; Yee, Karen W L
白血病
发表日期：2015
文献求助 收藏

Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103)

年龄对接受造血干细胞移植患者布苏凡药代动力学的影响；一项联盟研究（CALGB 10503、19808 和 100103）

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-014-2571-0
Beumer, Jan H; Owzar, Kouros; Lewis, Lionel D; Jiang, Chen; Holleran, Julianne L; Christner, Susan M; Blum, William; Devine, Steven; Kolitz, Jonathan E; Linker, Charles; Vij, Ravi; Alyea, Edwin P; Larson, Richard A; Ratain, Mark J; Egorin, Merrill J
细胞生物学
发育与干细胞
干细胞
发表日期：2014
文献求助 收藏

Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines

苯甲醛二甲磺酸盐（NSC 281612，DMS612）在人血和血浆中活性产物的形成及其对肾细胞癌细胞系的活性

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-012-1980-1
Parise, Robert A; Anyang, Bean N; Eiseman, Julie L; Egorin, Merrill J; Covey, Joseph M; Beumer, Jan H
肿瘤
肿瘤免疫
肾癌
多发性硬化症
细胞生物学
发表日期：2013
文献求助 收藏

Calcium carbonate does not affect nilotinib pharmacokinetics in healthy volunteers

碳酸钙不影响健康志愿者体内尼洛替尼的药代动力学。

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-013-2283-x
Tawbi, Hussein A; Tran, An L; Christner, Susan M; Lin, Yan; Johnson, Matthew; Mowrey, Emily; Appleman, Leonard R; Stoller, Ronald; Miller, Brian M; Egorin, Merrill J; Beumer, Jan H
发表日期：2013
文献求助 收藏

Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumors

17-二甲基氨基乙基氨基-17-去甲氧基格尔德霉素（17-DMAG）在成人实体瘤患者中的群体药代动力学分析

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-012-1859-1
Aregbe, Abdulateef O; Sherer, Eric A; Egorin, Merrill J; Scher, Howard I; Solit, David B; Ramanathan, Ramesh K; Ramalingam, Suresh; Belani, Chandra P; Ivy, Percy S; Bies, Robert R
MAG
发表日期：2012
文献求助 收藏

A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors

多西他赛联合脉冲剂量17-烯丙基氨基-17-去甲氧基格尔德霉素治疗成人实体瘤患者的I期临床试验

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-011-1789-3
Iyer, Gopa; Morris, Michael J; Rathkopf, Dana; Slovin, Susan F; Steers, Macaulay; Larson, Steven M; Schwartz, Lawrence H; Curley, Tracy; DeLaCruz, Anthony; Ye, Qing; Heller, Glenn; Egorin, Merrill J; Ivy, S Percy; Rosen, Neal; Scher, Howard I; Solit, David B
发表日期：2012
文献求助 收藏

Phase I trial of the combination of flavopiridol and imatinib mesylate in patients with Bcr-Abl+ hematological malignancies

黄酮吡啶醇联合甲磺酸伊马替尼治疗Bcr-Abl阳性血液系统恶性肿瘤患者的I期临床试验

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-012-1839-5
Bose, Prithviraj; Perkins, Edward B; Honeycut, Connie; Wellons, Martha D; Stefan, Tammy; Jacobberger, James W; Kontopodis, Emmanouil; Beumer, Jan H; Egorin, Merrill J; Imamura, Chiyo K; Douglas Figg, W Sr; Karp, Judith E; Koc, Omer N; Cooper, Brenda W; Luger, Selina M; Colevas, A Dimitrios; Roberts, John D; Grant, Steven
肿瘤
肿瘤免疫
发表日期：2012
文献求助 收藏